Back to Journal

SM Journal of Biology

The Advantages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery Systems

[ ISSN : 2573-3710 ]

Abstract Citation THE CAPACITY TO DELIVER BOTH SOLUBLE CARGOES AND MEMBRANE BOUND THERAPEUTIC MOLECULES GOOD STABILITY BOTH IN VITRO AND IN VIVO THE ABILITY TO INFILTRATE AND PENETRATE TISSUES AND THE BLOOD-BRAIN BARRIER TISSUE AND ORGAN TROPISMS GOOD BIOAVAILABILITY AND BIOCOMPATIBILITY LOW IMMUNOGENICITY AND GOOD SAFETY IMMUNE EVASION MODIFICATION FLEXIBILITY ACKNOWLEDGEMENTS AUTHOR CONTRIBUTIONS FUNDING CONFLICT OF INTERESTS REFERENCES
Details

Received: 30-Jun-2025

Accepted: 08-Aug-2025

Published: 09-Aug-2025

Xiubin Kuang1†, Jun Peng1†, Yingying Peng1 , Chen Huang2* and Zhengqiang Yuan1*

1 School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, China

2 The Affiliated Panyu Central Hospital of Guangzhou Medical University, China

Corresponding Author:

Chen Huang, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 511400, P. R. China † These authors contributed to this work equally

Abstract

Extracellular vesicles (EVs) are nanosized particles, secreted by most, if not all cell types, enclosed by a bilayer phospholipid membrane, and mediate crucial intercellular communications by carrying and transporting many active biological molecules. These naturally occurred nanoparticles are emerging as a promising drug delivery system. In particular, EVs from mesenchymal stem cells (MSC-EVs) offer numerous advantages as drug delivery vehicles due to their unique features, as briefly reviewed below in Figure 1.

Citation

Kuang X, Peng J, Peng Y, Huang C, Yuan Z (2025) IThe Advan tages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery Systems. SM J Biol 7: 4.

THE CAPACITY TO DELIVER BOTH SOLUBLE CARGOES AND MEMBRANE BOUND THERAPEUTIC MOLECULES

MSC-EVs have the capability to deliver a variety of therapeutic cargoes, including soluble agents like small molecule drugs and RNAs as well as membrane-integrated therapeutic molecules such as proteins and antibodies [1,2]. By encapsulating these therapeutic molecules, MSC-EVs not only enhance the stability and bioavailability of the drugs but also enable co-delivery of synergistic drugs [3,4]. For example, chemotherapy drugs doxorubicin with miR-159 or 5-fluorouracil (5-FU) with miR 21i could be co-delivered for synergistic anticancer therapies [5,6]. Previously we genetically transduced MSCs to express the proapoptotic tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [7] and found the transduced cells secreted EV-membrane incorporated TRAIL (EV-T) [8]. Further we encapsulated the chemotherapy dinaciclib (Dina) into EV-T to fabricate a complexed nanodrug Dina@EV-T, which overcame TRAIL resistance and showed strikingly augmented anticancer efficacy by either intravenous (i.v.) [4] or nebulized administration [9]. Additionally, the CDK9-targetting siRNA could be loaded into EV-T for precision anticancer medicine [10]. Therefore, MSC-EV mediated co-delivery of drugs enables high efficacy of combinatory therapies.

Figure 1: Summary of the Advantages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery Systems.

GOOD STABILITY BOTH IN VITRO AND IN VIVO

As the natural drug carrier, MSC-EVs have shown good stability both in vitro and in vivo [9]. The membrane structure of EVs forms a natural and biocompatible platform to not only protect the enclosed drugs from premature degradation by enzymes and other degradative processes, but also help in maintaining the stability of labile therapeutics. The in vivo stability of EVs was proposed to be further enhanced by the coating of an albumin-enriched protein corona and consequent immune evasion [11].

THE ABILITY TO INFILTRATE AND PENETRATE TISSUES AND THE BLOOD-BRAIN BARRIER

EVs have innate capacity to cross various biological barriers including the blood-brain barrier (BBB) [12]. The tissue permeability of nanomedicines was traditionally assumed to be mainly mediated by the enhanced permeability and retention (EPR) effect. However, the advancements in this area have unveiled a possible transcytosis mechanism, by which EVs can migrate through endothelial cells [13]. This property highlights the attractive potential of EV-based therapies for brain disorders and tumors [14]. Indeed, MSC-EVs have been recently harnessed to successfully deliver therapeutic siRNAs to the striatum of mice brain, leading to the synergistic alleviation of neuronal death in a model of Parkinson’s disease (PD) [12].

TISSUE AND ORGAN TROPISMS

The tropism of MSC-EVs to certain damaged, inflammatory or diseased tissue and organs enable targeted delivery of therapeutic agents [4-15]. This phenomenon is likely mediated by EV surface molecules, such as tetraspanins, latex adhesion proteins, and integrins [16]. As an instance, MSC-EVs showed preferential tropism to animal acute lung injury (ALI), by contrast, HEK293T cells-derived EVs were mainly accumulated in the spleen and liver [17]. The systemically infused MSC-EVs were found to penetrate and accumulate in tumors, suggesting their feasibility for delivery of tumor-targeting therapy. [4] For example, doxorubicin encapsulated MSC-EVs were revealed to home to osteosarcoma via a CXCR4-SDF1 axis, resulting in enhanced anticancer activity [18].

GOOD BIOAVAILABILITY AND BIOCOMPATIBILITY

Compared to synthetic carriers such as liposomes or other nanoparticles, MSC-EVs demonstrated good biocompatibility and bioavailability as drug delivery systems [1,2]. As carriers, EVs can transport their cargo across cell membranes to specific intracellular locations. Importantly, the lipid membrane structure renders MSC-EVs good biological barrier penetrating capacity, in vivo stability, reduced immune clearance, and consequently improved drug delivery efficiency [19]. Furthermore, the low immunogenicity and good tolerability of MSC EVs allow for their safe use in vivo, minimizing the risk of eliciting adverse reactions [4]. The desirable biocompatibility and bioavailability make MSC-EVs ideal candidates for drug delivery carriers.

LOW IMMUNOGENICITY AND GOOD SAFETY

MSC-EVs are increasingly recognized for their low immunogenicity, a characteristic pivotal to their therapeutic potential in various diseases [20]. Certain EV surface components, such as galectins, integrins, and tetraspanins, play a masking role from the immune system leading to the low immunogenicity of MSC-EVs [21]. Additionally, the EV surface glycans and lipids also act as key signaling molecules to influence the immunogenicity, with the glycan composition dictating cellular internalization and biodistribution, while lipids contributing to intercellular communication and immune modulation [21]. It is well known that major histocompatibility complex (MHC) molecules are crucial for antigen presentation to trigger immune responses, thus play an important role for immunogenicity. MSC-EVs have been revealed to be negative for MHC expression, indicating their low immunogenicity [22]. Actually, the systemic administration of MSC-EVs did not cause any adverse side effects on liver function, blood cell counting and organ physiology in experimental animals [4].

In the realm of safety evaluation, the administration of extracellular vesicles (EVs) has demonstrated notable superiority. Preclinical studies have revealed the superior efficacy, safety, and versatility of MSC-EV therapies compared to the MSC therapy, suggesting the satisfactory safety of MSC-EV delivery of therapeutics for disease treatment [23]. Indeed, over 20 completed or ongoing MSC-EV clinical trials have demonstrated good safety and certain efficacies in various diseases.[20] Moreover, in a phase 1 clinical trial, 24 healthy volunteers were administered of 2–16×108 allogeneic MSC-EV particles by inhalation, and all showed good tolerance to the infusion without any adverse reactions observed [24].

IMMUNE EVASION

The application of nanomedicine faces a huge challenge, i.e., the rapid uptake and subsequent clearance of nanoparticles from the bloodstream by the mononuclear phagocyte system (MPS) [25]. Interestingly, the integrin-associated protein CD47 was found to express on MSC-EVs [4] and act as a marker of self to prevent clearance by the MPS in the liver and spleen [26]. This feature allows phagocytic evasion of MSC-EVs, and provides an approach for improving pharmacokinetics of therapeutics and thus potentially enhancing therapeutic efficacies. This advantage underscores the versatility and potential of MSC-EVs as a drug delivery vehicle for therapeutic applications [27].

MODIFICATION FLEXIBILITY

The enclosed lipid membrane structure and specific surface compositions enable flexible modification of MSC-EVs for either the targeted delivery of therapeutics or EV labelling and tracking within cells or tissues. There are various EV surface modification strategies available, including genetic engineering or metabolic engineering of EV-producing cells, click chemistry, ligand-receptor interaction, hydrophobic interaction, and anchoring peptide or aptamer-mediated modifications. [28] Also, different labelling approaches have been developed for EV imaging, pharmacokinetic investigation, or examination of in vivo biodistribution, such as bioluminescent, fluorescent, or radioactive labelling. [4-28] Furthermore, both drug pre-loading and post-loading strategies can be applied to engineer MSC-EVs for enhanced therapeutic efficacies. [4-30] Despite the aforenoted versatility and potential, one must be careful to determine MSC-EV modification strategies, considering the modifications may cause undesired immunogenicity, reduced physicochemical stability,and the biosafety concern.[28]

In summary (Figure.2), MSC-derived extracellular vesicles offer several advantages as drug delivery systems. They exhibit high biocompatibility and low immunogenicity, ensuring safe administration. These vesicles can efficiently target specific tissues and cells, enhancing therapeutic efficacy. Additionally, they are capable of carrying a diverse range of therapeutic molecules, including proteins, RNA, and small molecules. Their nanoscale size allows for easy penetration into tissues, and they can be readily produced and stored, making them a practical option for clinical applications.

Figure 2: Extracellular vesicles mediate antigen presentation, immune modulation, and tissue repair. They can also be used as adaptable drug delivery vehicles and diagnostic tools.

ACKNOWLEDGEMENTS

Z.Q.Y. is a China Talented Scholar Scheme Research Fellow in the School of Biomedical and Pharmaceutical Sciences and is supported by the Guangdong Provincial Talented Scholar Foundation (220418137).

AUTHOR CONTRIBUTIONS

Z.Q.Y provided the theme and framework for the review, and along with C.H, he was responsible for the final proofreading and editing of the article, as well as the approval of the final version. X.B.K and J.P contributed equally to the drafting and revision, and Y.Y.P participated the writing of the manuscript.

FUNDING

This work has been supported by National Natural Science Foundation of China (grant number 82173850), Guangdong Medical Science and Technology Research Fund (A2024625), and Guangzhou Science and Technology Planning Project (202103000002).

CONFLICT OF INTERESTS

The authors declare no any financial, proprietary, or commercial interests in the writing of this article.

REFERENCES

1. Liu Q, Li D, Pan X, Liang Y. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnology. 2023; 21: 334.

2. Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022; 203: 115167.

3. Chen H, Yao H, Chi J, Li C, Liu Y, Yang J et al. Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics? Front Bioeng Biotechnol. 2023; 11: 1254356.

4. Ke C, Hou H, Su K, Huang C, Yuan Q, Li S, et al. Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors. Biomater Sci. 2022; 10: 1498-1514.

5. Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, et al. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnology. 2019; 17: 93.

6. Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology. 2020; 18: 10.

7. Yuan Z, Kolluri KK, Sage EK, Gowers KH, Janes SM. Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy. Cytotherapy. 2015; 17: 885-896.

8. Yuan Z, Kolluri KK, Gowers KH, Janes SM. TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy. J Extracell Vesicles. 2017; 6: 1265291.

9. Yuan Q, Su K, Li S, Long X, Liu L, Yang M et al. Pulmonary Delivery of Extracellular Vesicle-Encapsulated Dinaciclib as an Effective Lung Cancer Therapy. Cancers (Basel). 2022; 14: 3550.

10. Yuan Q, Su K, Li S, Long X, Liu L, Sun J et al. Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway. Apoptosis. 2023; 28: 1060-1075.

11. Liam-Or R, Faruqu FN, Walters A, Han S, Xu L, Wang JT et al. Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nat Nanotechnol. 2024; 19: 846-855.

12. Geng Y, Long X, Zhang Y, Wang Y, You G, Guo W et al. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson’s disease via m6A-dependent regulation of ATM mRNA. J Transl Med .2023; 21: 652.

13. Ramos-Zaldívar HM, Polakovicova I, Salas-Huenuleo E, Corvalán AH, Kogan MJ, Yefi CP et al. Extracellular vesicles through the blood-brain barrier: a review. Fluids Barriers CNS. 2022; 19: 60.

14. Bhom N, Somandi K, Ramburrun P, Choonara YE. Extracellular nanovesicles as neurotherapeutics for central nervous system disorders. Expert Opin Drug Deliv. 2025; 22: 69-84.

15. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367.

16. Edelmann MJ, Kima PE. Current understanding of extracellular vesicle homing/tropism. Zoonoses (Burlingt) 2022; 2: 14.

17. Tieu A, Stewart DJ, Chwastek D, Lansdell C, Burger D, Lalu MM. Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury. Stem Cell Res Ther. 2023; 14: 250.

18. Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y et al. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis. Int J Nanomedicine. 2022; 17: 3483-3495.

19. Xu F, Luo S, Lu P, Cai C, Li W, Li C. Composition, functions, and applications of exosomal membrane proteins. Front Immunol. 2024; 15: 1408415.

20. Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023; 14: 66.

21. Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of Extracellular Vesicles. Adv Mater. 2024; 36: e2403199.

22. Desgeorges A, Hollerweger J, Lassacher T, Rohde E, Helmbrecht C, Gimona M. Differential fluorescence nanoparticle tracking analysis for enumeration of the extracellular vesicle content in mixed particulate solutions. Methods. 2020; 177: 67-73.

23.Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci. 2017; 18: 1852.

24. Shi MM, Yang QY, Monsel A, Yan JY, Dai CX, Zhao JY et al. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles. J Extracell Vesicles. 2021; 10: e12134.

25. Zelepukin IV, Shevchenko KG, Deyev SM. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nat Commun. 2024; 15: 4366.

26. Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G et al. Smart exosomes enhance PDAC targeted therapy. J Control Release. 2024; 368: 413-429.

27. Ulpiano C, da Silva CL, Monteiro GA. Bioengineered Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles as an Improved Drug Delivery System: Methods and Applications. Biomedicines. 2023; 11: 1231.

28. Salunkhe S, Dheeraj, Basak M, Chitkara D, Mittal A. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance. J Control Release. 2020; 326: 599-614.

29. Walker S, Busatto S, Pham A, Tian M, Suh A, Carson K et al. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics. 2019; 9: 8001-8017.

30. Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014; 192: 262-270.

Other Articles

Article Image 1

Graph Theory: A Powerful Research Tool for Biological Network Analysis

In the pre-genome era, traditional molecular biology provides very informative knowledge on how individual bio-molecule, i.e. DNA, RNA and protein, perform biological functions. Networks of interactions among bio-molecules are fundamental to all biological processes; for example, the Gene Regulatory Network (GRN) can be described as a complex network of genes regulated by protein binding. Cellular processes are controlled by various types of biochemical networks; such as (i) metabolic networks, (ii) Protein-Protein Interaction (PPI) networks, (iii) GRN, and (iv) signal transduction networks. Biochemical networks are complex in nature; they consist of a large number of bio-molecules, interacting with each other give rise to biological responses and stabilities. In the post-genome era, it is more productive to investigate how bio-molecules regulate or cooperate on a system level. The graph theory approach is a powerful tool for investigating the underlying topological structures of different molecular networks. A great diversity of graph theoretical notions is discussed to characterize biological networks. T he theory of complex networks plays an important role, ranging from computer science, sociology, engineering and physics, to bioinformatics etc. Within the fields of bioinformatics, potential applications of network analysis include drug target identification, determining bio molecules’ pathways and function, and designing effective strategies for treating various diseases. Molecular networks are the basis of biological processes. Such networks can be decomposed into smaller modules, also known as network motifs. These motifs show interesting dynamical behaviors, in which co-operatively effects between the motif components play a critical role in human diseases. Some of the network motifs are interconnected which can be merged together and form more complex structures, the so-called Coupled Motif Structures (CMS). These structures exhibit mixed dynamical behavior, which may lead biological organisms to perform specific functions.

Chien-Hung Huang*


Article Image 1

Carbapenem-Resistant Acinetobacter baumannii: Epidemiology and Prevention in Iran

Over the past 10 years, dissemination of Carbapenem-Resistant Acinetobacter baumannii (CRAB) has led to an increase in the prevalence of Carbapenem-resistant Gram negative bacteria in the Iran. Carbapenems are used as a first choice drug for treatment of Acinetobacter baumannii infections. Extensive resistance to Carbapenemes, has become a major challenge for treatment of Acinetobacter baumannii infections. Infections caused by CRAB have limited treatment options and have been associated with high mortality rates in worldwide. Resistance to Carbapenemes first was reported in 1991 than its distribution was observed worldwide. Recent studies have revealed that 98% of Acinetobacter baumannii isolates in different Tehran hospitals are resistant to Carbapenemes (Imipenem and Meropenem). While the rate of resistance to Carbapenemes was reported to be 52/5% in 2009. Several mechanisms are involved in developing of CRAB. These mechanisms include the enzymatic hydrolysis mediated by the oxacillinases of Ambler class D OXA-type, Carbapenem hydrolyzing-β-lactamases of molecular class B and sometimes alteration of Penicillin-Binding Proteins (PBP) or increased activity efflux pumps [1]. Metallo-β-Lactamases (MBL) and oxacillinases are found to be more frequent. So far the oxacillinase genes such as blaOXA-23-like, blaOXA-24-like, blaOXA-51-like and blaOXA-58 like also MBLs such as Seoul metallo-β-lactamase Imipenemase (SIM), Sno Paolo metallo (SPM), New Delhi Metallo-β-lactamase (NDM), Verona Integron-encoded Metallo-β-lactamases (VIM) and Imipenemase (IMP) have been reported in Acinetobacter baumannii isolates. There have been numerous studies performed aiming to identify these mechanisms in Iran [2].

Habibeh Adibhesami1, Abbas Farahani2, Arezoo Asadi3 and Davoud Afshar1*


Article Image 1

An Epidemiologic Survey on Trichomonas Vaginalis Infection in Pregnant Women of Urmia City, North West of Iran, 2015

Background: Trichomoniasis is an extremely common infection worldwide and is associated with important public healthproblems, including amplification of HIV transmission. This symptomatic and asymptomatic disease is more frequently in pregnant women due to hormonal changes and reducing the vaginal acidity during pregnancy. Thus the aim of this study was to evaluate Trichomonas vaginalis infection in pregnant women of Urmia city, North West of Iranfor the first time in 2015.

Methods: This descriptive cross-sectional study was conducted on 800 pregnant women who referred to main medical laboratories in Urmia. Vaginal samples were obtainedfrom them and examined by wet mount and culture methods for the detection of T. vaginalis.

Results: According to the results, T. vaginalis was detected in 29 out of 800 participants (3.63%) by using culture methods whereas only 22 of 29 infected people were positive with the wet mount technique. Gestational age had a significant relation with Trichomoniasis (P<0.05) while age and symptoms showed no significant relation with Trichomoniasis (P>0.05).

Conclusion: This study showed low prevalence of T. vaginalis infection in the study population.Since clinical signs of trichomonal vaginitis are the same of other Sexually Transmitted Diseases (STD), a confirmatory laboratory diagnosis is necessary. Wet mount technique is not as well as culture method sensitive and accurate for detection of T. vaginalis.

Reza Abdolah Nezhad1* and Farzaneh Kaffashi Boukani2


Article Image 1

Stroma Features in Prostate Cancer Diagnosis and Prognosis

The oncogenesis of Prostate Cancer (PCa) is a process involving epithelial cells of the gland and their interaction with the stroma. Reactive stroma formation has been shown to be critical in the progression of many cancers. In PCa, the reactive stroma is unique when compared with other cancer types and characterized by replacing the normal well differentiated smooth muscle cells with fibroblasts and myofibroblasts. The Masson’s trichrome stain and immunohistochemistry (IHC) / immunofluorescence studies characterized these changes and a grading system of reactive stroma has been developed. In this review, the changes of the molecular and morphometric features of the reactive stroma during the progress of PCa, and their use in clinical implications in the diagnosis, prognosis prediction and potential treatment of PCa are discussed.

Guangjing Zhu1* and Robert W Veltri1


Article Image 1

The Impact of Seed-Borne Fungi Associated with Roasted Cashew (Anacardium Occidentale L) Nuts on Its Food Value, Mineral and Anti-Nutrient Contents and Human Health

Isolation and identification of seed-borne fungi associated with cashew nuts from source of production and market was carried out. The proximate, mineral and anti-nutrient composition of the source of production and the market samples of roasted cashew nuts were also investigated. The result of isolation of fungi associated with the nuts from source of production and the market showed that Claviceps purpurea, Aspergillus fischeri, Aspergillus carbonarius, Aspergillus flavus, Aspergillus tamrii and Aspergillus fumigatus were associated with seeds from samples from the two sources. The ash, lipid, carbohydrate and protein contents of the source sample were relatively higher, while the moisture, fibre and vitamin C content of the markets samples were relatively lower. The Sodium, Zinc, Nitrate, Nitrogen and phosphorus contents of the market samples were observed to be higher when compared with the source sample, while the phosphate, Magnesium, Calcium, Manganese and Copper contents of the source samples were higher than the market sample. The saponin and the cyanogenic glycoside content of both market and source samples was the same, while the alkaloid content of the source samples were relatively higher. The flavonoid content of the market sample was observed to be higher when compared with the source samples.

Ibiam, O. F. A1*, Nweke, A1 and Kanayochukwu, U. L2


Article Image 1

Properties and Applications of Plants of Origanum Sp. Genus

The genus Origanum consists of different aromatic and medicinal plants some of which are used in folk medicine and as food additives since ancient times. These plants have numerous and varied beneficial properties, among which are antibacterial, antifungal, antioxidant, anti-inflammatory, antitumor and antiviral. While a mixture of components present naturally in these plants confers myriad of benefits phenolic compounds in particular have great importance in biocidal and antioxidants properties. In this review we focus on the genus Origanum, discussing the beneficial and probed properties that have potential implications in health-care and dietetics.

José María García-Beltrán1 and María Ángeles Esteban1*


Article Image 1

The Role of Chloroplast Signals in Cold Acclimation in Arabidopsis

In the post-genome era, one of the main problems of plant genetics is to identify functions of genes. A massive change in gene expression is an important component of the cold acclimation process [1]. Around one thousand genes have been found to be differentially expressed following cold exposure in the model plant Arabidopsis thaliana. Transcriptional re-programming occurs during cold acclimation to induce expression of around 100 Cold-Regulated (COR) genes, responsible for producing cryoprotective molecules. Central to this transcriptional regulation are the CBF (C-repeat-Binding Factor) genes that encode AP2/ERF family transcription factors [2]. A general scheme of genetic control of cold stress responses can be represented as a network of transcription factors and genes that are directly responsible for morphological changes leading to cold resistance. It is well known that there are two main pathways of cold response: ABA-dependent and ABA-independent. There is also an intersection between abiotic and biotic response pathways as well as between different kinds of abiotic response pathways such as cold, dehydration and high light [3]. However, functions of most cold response genes are still not found. On the other hand, the agricultural range of many important crop species is limited by their maximum freezing tolerance capacity, and freezing stress-related damage can result in considerable crop productivity losses [4].

Novokreshchenova MG*


Article Image 1

The Technology Explosion in Biology and its Implications for Biotechnology and the Potential of Systems and Synthetic Biology

Technological and scientific breakthroughs have added novel products to those traditionally produced by biological means. In this letter to the editor, some of these recent trends are summarized to raise the awareness of the power of Biotechnology.

J Stefan Rokem*


Article Image 1

Unravelling Rhizospheric Diversity and Potential of Phytase Producing Microbes

Phosphorus (P) is considered the ultimate limiting nutrient for plants because of its form as insoluble complexes. To address P deficiency, different organic and inorganic fertilizers are added to soils. Inorganic P instantly become unavailable by forming complexes with metal ions and excess P-fertilizers application also leads to water eutrophication of P. Phytic Acid (PA; constitutes 15-50% of total P depending on soil types) as a component of organic P also form stable complexes and its natural degradation is almost impossible. Therefore, role of P solubilizing microbes in rhizosphere become important for P cycling. Several rhizospheric bacterial and fungal species have been reported to play important role in P solubilization in soil [1]. Based on several studies on diversity of P solubilizing microbes and enzymes in varying agro-ecosystems, soil P availability and its uptake by plants is mainly attributed to microbial phosphatases and plant exudates. Phytase producing microbes have gained recent interest due to their plant growth promoting abilities and P pollution management applications [2,3].

Vinod Kumar*, Ajar Nath Yadav, Abhishake Saxena, Punesh Sangwan and Harcharan Singh Dhaliwal


Article Image 1

Isolation and Identification of Diterpenes Extracted from Annona Squamosa

A. squamosa is belongs to the Annonaceae family. Its common names are Nona, sugar apple, ata, gishta and sweet sop plant [1,2]. The genus Annona comprises 120 species. An economically significant species is A. squamosa which belongs to the Annonaceae family. Its specific native range is indefinite because of widespread commercial cultivation but is generally deemed to originate from the Caribbean region [3]. Common names for this plant are Nona, sugar apple, ata, gishta and sweet sop [1,2]. It is a small semi-evergreen tree/shrub, 3-7 m tall, with irregular or crown branches. The leaves are oblong-lanceolate and pale green on both surfaces. The flowers are greenish-yellow and produced in single or short lateral clusters [4]. The petioles are green and 0.6-1.3 cm in length. The fruit of this plant is round, heart shaped, ovate or conical. It is green-yellow in colour initially. The ripe fruit is white with the sweetly aromatic pulp also white [1]. The seeds are shiny, numerous, and blackish or dark brown in colour [5]. It is used as a medicine for a general tonic, enriches blood, relieves vomiting, cancer, vermicide, skin complaints and also used for applied wounds and ulcer [4,6,7].

Abdul Mushin M Shami*